PD Dr. Michael Erdmann

Department of Dermatology

Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics (2024) Haggenmüller S, Schmitt M, Krieghoff-Henning E, Hekler A, Maron RC, Wies C, Utikal JS, et al. Journal article Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning (2024) Hekler A, Maron RC, Haggenmüller S, Schmitt M, Wies C, Utikal JS, Meier F, et al. Journal article Spatial cell graph analysis reveals skin tissue organization characteristic for cutaneous T cell lymphoma (2024) Sarkar S, Möller A, Hartebrodt A, Erdmann M, Ostalecki C, Baur A, Blumenthal DB Journal article, Original article Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma - A Single Center Analysis (2023) Glaser N, Petzold A, Wessely A, Kaufmann M, Koch E, Knorr H, Voskens C, et al. Journal article Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study (2023) Lodde GC, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study (2023) Kirchberger M, Gfesser M, Erdmann M, Schliep S, Berking C, Heppt M Journal article S1-Leitlinie dermales und subkutanes Leiomyosarkom (2023) Helbig D, Dippel E, Erdmann M, Frisman A, Kage P, Leiter U, Mentzel T, et al. Journal article Opportunities to inform German residents about the possibility of skin cancer screening and to inform stakeholders to take appropriate actions: A qualitative approach (2023) Steeb T, Wessely A, Heppt M, Erdmann M, Klug SJ, Berking C Journal article Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas (2023) Koch E, Erdmann M, Berking C, Kiesewetter F, Kramer R, Schliep S, Heppt M Journal article Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors (2023) Nuñez NG, Berner F, Friebel E, Unger S, Wyss N, Gomez JM, Purde MT, et al. Journal article